Journal
LIVER INTERNATIONAL
Volume 32, Issue -, Pages 151-156Publisher
WILEY
DOI: 10.1111/j.1478-3231.2011.02706.x
Keywords
delivery of health care; barriers to care; health services accessibility; hepatitis C; therapy
Categories
Funding
- National Institutes of Health [T32 DK07634, K24 DK066144]
Ask authors/readers for more resources
Despite the availability of highly effective therapy for hepatitis C virus (HCV) infection, few patients receive treatment. Barriers arising at multiple levels, from diagnosis to specialist referral, may impede the delivery of hepatitis C care. At the patient level, lack of awareness, fear of side effects, poor adherence and comorbid conditions may prevent treatment. For providers, limited knowledge, lack of availability and communication difficulties may be problematic. At the government and payer level, a lack of promotion, surveillance and funding may interfere. Each of these barriers needs to be addressed if wider implementation of antiviral therapy is to be achieved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available